Cyclodextrins applied to the treatment of lysosomal storage disorders
Author:
Funder
AMED
Japan Society for the Promotion of Science
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference173 articles.
1. Inherited disorders of lysosomal membrane transporters;Huizing;Biochim. Biophys. Acta, Biomembr.,2020
2. Treating lysosomal storage disorders: What have we learnt?;Lachmann;J. Inherit. Metab. Dis.,2020
3. Fabry Disease: The Current Treatment Landscape;Lenders;Drugs.,2021
4. COMET Investigator Group, Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial;Diaz-Manera;Lancet Neurol.,2021
5. B.K. Burton, M. Balwani, F. Feillet, I. Barić, T.A. Burrow, C. Camarena Grande, M. Coker, A. Consuelo-Sánchez, P. Deegan, M. Di Rocco, G.M. Enns, R. Erbe, F. Ezgu, C. Ficicioglu, K.N. Furuya, J. Kane, C. Laukaitis, E. Mengel, E.G. Neilan, S. Nightingale, H. Peters, M. Scarpa, K.O. Schwab, V. Smolka, V. Valayannopoulos, M. Wood, Z. Goodman, Y. Yang, S. Eckert, S. Rojas-Caro, A.G. Quinn, A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency, N Engl J Med. 373 (2015) 1010–1020. 10.1056/NEJMoa1501365.
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the binding process of lutein with hydroxypropyl-β-cyclodextrin: Multispectral and molecular simulation study;Food Hydrocolloids;2024-11
2. Solubilization techniques used for poorly water-soluble drugs;Acta Pharmaceutica Sinica B;2024-09
3. Intracerebroventricular 2-hydroxypropyl-γ-cyclodextrin alleviates hepatic manifestations without distributing to the liver in a murine model of Niemann–Pick disease type C;Life Sciences;2024-08
4. Enzyme/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating;Journal of Nanobiotechnology;2024-07-26
5. CYCLODEXTRIN AS SOLUBILIZER AND TARGETING AGENT FOR DRUGS;International Journal of Applied Pharmaceutics;2024-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3